VYNE Therapeutics Inc. (VYNE) › Capital ExpendituresVYNE Therapeutics Inc. (VYNE) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2023: $02024: $117.0K2025: $0$02023Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$0-100.0%2024$117.0K—2023$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share